Oragenics (NYSE-MKT: OGEN)

Oragenics, Inc. is focused on becoming the world leader in novel antibiotics against infectious disease and probiotics for oral health in humans and pets. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation Inc., a synthetic biology company. The collaborations will allow Oragenics access to Intrexon's proprietary technologies with the idea of accelerating the development of much needed new antibiotics that will work against resistant strains of bacteria and new therapeutic probiotics designed to alleviate symptoms from oral diseases. Oragenics also develops, markets and sells proprietary OTC probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora in more than 13 countries worldwide.

Find a broker to begin trading OGEN now

Company Name Oragenics
Market/Symbol NYSE-MKT: OGEN
Recent Price
Market Cap $21.46M
Avg. Daily Vol. (3m) 74,081
Price/Book N/A
Price/Cash Flow N/A
As of Oct. 20, 2016
*Source: QuoteMedia

Begin trading OGEN

 Find Broker

Recent Company Videos

Oragenics (NYSE MKT: OGEN) - RedChip Global Online CEO Conference

Apr. 24, 2014

Presentation and Investor Q&A with John Bonfiglio, President & CEO of Oragenics (NYSE MKT: OGEN) a leader in the development of novel.

Oragenics Latest News

Ask the CEO

Meet The Board of Directors

Frederick W. Telling

Chairman of the Board, Chairman of the Compensation Committee

Charles L. Pope

Director and Chairman of the Audit Committee

Alan Dunton

Director and Member of the Audit Committee

Robert Koski

Director and Chairman of the Nomination Committee

Christine Koski


John Bonfiglio

Chief Executive Officer and Director

Meet The Management Team

Michael Sullivan

Chief Financial Officer

Dr. Martin Handfield

Vice President of Research

Historical SEC Filings

RedChip Direct Investment Opportunities For Private and Public Companies

Receive OGEN Email Alerts

*By entering your information you agree to our privacy policy.

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market